Ralph M. Schapira
Medical College of Wisconsin
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ralph M. Schapira.
The American Journal of Medicine | 2000
Richard M. Effros; Elizabeth R. Jacobs; Ralph M. Schapira; Julie Biller
Aspiration of acid from the stomach and water from the mouth can cause significant lung injury. Animal experiments suggest that acid entering the lungs is normally neutralized by bicarbonate derived from the plasma. It is hypothesized that this process may be impaired in patients with cystic fibrosis and that some of the airway injury that they experience may be related to this defect. This disease is characterized by abnormalities in the cystic fibrosis transmembrane conductance regulator, which normally conducts bicarbonate and chloride exchange. Evidence is discussed regarding the role of water channels (aquaporins) in transporting water from the airspaces into the vasculature.
Pediatric Research | 2003
Leif D. Nelin; James F Morrisey; Richard M. Effros; Christopher A. Dawson; Ralph M. Schapira
Inhaled nitric oxide (iNO) is used as a selective pulmonary vasodilator, and often under conditions when a high fraction of inspired oxygen is indicated. However, little is known about the potential toxicity of iNO therapy with or without concomitant oxygen therapy. NO can combine with superoxide (O2−) to form peroxynitrite (ONOO−), which can in turn decompose to form hydroxyl radical (OH·). Both OH· and ONOO− are involved in various forms of lung injury. To begin evaluation of the effect of iNO under either normoxic or hyperoxic conditions on OH· and/or ONOO− formation, rats were exposed for 58 h to either 21% O2, 21% O2 + 10 parts per million (ppm) NO, 21% O2 + 100 ppm NO, 50% O2, 90% O2, 90% O2 + 10 ppm NO, or 90% O2 + 100 ppm NO. We used a salicylate hydroxylation assay to detect the effects of these exposures on lung OH· and/or ONOO− formation measured as the appearance of 2,3-dihydroxybenzoic acid (2,3-DHBA). Exposure to 90% O2 and 90% O2 + 100 ppm NO resulted in significantly (p < 0.05) greater lung wet weight (1.99 ± 0.14 g and 3.14 ± 0.30 g, respectively) compared with 21% O2 (1.23 ± 0.01 g). Exposure to 21% O2 + 100 ppm NO led to 2.5 times the control (21% O2 alone) 2,3 DHBA formation (p < 0.05) and exposure to 90% O2 led to 2.4 times the control 2,3-DHBA formation (p < 0.05). However, with exposure to both 90% O2 and 100 ppm NO, the 2,3-DHBA formation was no greater than the control condition (21% O2). Thus, these results indicate that, individually, both the hyperoxia and the 100 ppm NO led to greater salicylate hydroxylation, but that the combination of hyperoxia and 100 ppm NO led to less salicylate hydroxylation than either did individually. The production of OH· and/or ONOO− in the lung during iNO therapy may depend on the ratio of NO to O2.
American Journal of Respiratory Cell and Molecular Biology | 1994
Ralph M. Schapira; Andrew J. Ghio; Richard M. Effros; James F Morrisey; Christopher A. Dawson; Allen D..Hacker
American Journal of Respiratory Cell and Molecular Biology | 1995
Ralph M. Schapira; Andrew J. Ghio; Richard M. Effros; James F Morrisey; Urias A. Almagro; Christopher A. Dawson; Allen D..Hacker
American Journal of Respiratory Cell and Molecular Biology | 1998
Ralph M. Schapira; John H. Wiessner; James F Morrisey; Urias A. Almagro; Leif D. Nelin
American Journal of Respiratory Cell and Molecular Biology | 2002
Leif D. Nelin; Gary S. Krenz; Louis G. Chicoine; Christopher A. Dawson; Ralph M. Schapira
Journal of Applied Physiology | 1998
W. Lin; Elizabeth R. Jacobs; Ralph M. Schapira; Kenneth W. Presberg; Richard M. Effros
Journal of Applied Physiology | 1998
Richard M. Effros; Ralph M. Schapira; Kenneth W. Presberg; K. Ozker; Elizabeth R. Jacobs
Journal of Applied Physiology | 1994
Richard M. Effros; C. Murphy; A. Hacker; Ralph M. Schapira; Robert D. Bongard
Chest | 1999
Richard M. Effros; Elizabeth R. Jacobs; Ralph M. Schapira; W. Lin; Kenneth W. Presberg